Farina L, Pareyson D, Minati L, Ceccherini I, Chiapparini L, Romano S, Gambaro P, Fancellu R, Savoiardo M
Department of Neuroradiology, Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy.
AJNR Am J Neuroradiol. 2008 Jun;29(6):1190-6. doi: 10.3174/ajnr.A1060. Epub 2008 Apr 3.
In recent years, the discovery that mutations in the glial fibrillary acidic protein gene (GFAP) were responsible for Alexander disease (AD) brought recognition of adult cases. The purpose of this study was to demonstrate that MR imaging allows identification of cases of AD with adult onset (AOAD), which are remarkably different from infantile cases.
In this retrospective study, brain and spinal cord MR imaging studies of 11 patients with AOAD (7 men, 4 women; age range, 26-64 years; mean age, 43.6 years), all but 1 genetically confirmed, were reviewed. Diffusion and spectroscopic investigations were available in 6 patients each.
Atrophy and changes in signal intensity in the medulla oblongata and upper cervical spinal cord were present in 11 of 11 cases and were the diagnostic features of AOAD. Minimal to moderate supratentorial periventricular abnormalities were seen in 8 patients but were absent in the 3 oldest patients. In these patients, postcontrast enhancement was also absent. Mean diffusivity was not altered except in abnormal white matter (WM). Increase in myo-inositol (mIns) was also restricted to abnormal periventricular WM.
Awareness of the MR pattern described allows an effective selection of the patients who need genetic investigations for the GFAP gene. This MR pattern even led to identification of asymptomatic cases and should be regarded as highly characteristic of AOAD.
近年来,胶质纤维酸性蛋白基因(GFAP)突变导致亚历山大病(AD)这一发现使得成人病例得到了认识。本研究的目的是证明磁共振成像(MR)能够识别成人起病型亚历山大病(AOAD)病例,这些病例与婴儿型病例显著不同。
在这项回顾性研究中,对11例AOAD患者(7例男性,4例女性;年龄范围26 - 64岁;平均年龄43.6岁)的脑和脊髓MR成像研究进行了回顾,除1例患者外,其余均经基因确诊。6例患者可进行扩散和波谱研究。
11例患者中有11例延髓和颈上段脊髓出现萎缩及信号强度改变,这是AOAD的诊断特征。8例患者可见轻度至中度幕上脑室周围异常,但3例年龄最大的患者未出现。这些患者也无增强后强化表现。除异常白质(WM)外,平均扩散率未改变。肌醇(mIns)升高也仅限于脑室周围异常WM。
了解所描述的MR表现有助于有效选择需要进行GFAP基因遗传学检查的患者。这种MR表现甚至能识别无症状病例,应被视为AOAD的高度特征性表现。